|
1
|
Li Y, Zeng M, Chen W, Liu C, Wang F, Han
X, Zuo Z and Peng S: Dexmedetomidine reduces isoflurane-induced
neuroapoptosis partly by preserving PI3K/Akt pathway in the
hippocampus of neonatal rats. PLoS One. 9:e936392014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Van Schaeybroeck S, Kalimutho M, Dunne PD,
Carson R, Allen W, Jithesh PV, Redmond KL, Sasazuki T, Shirasawa S,
Blayney J, et al: ADAM17-dependent c-MET-STAT3 signaling mediates
resistance to MEK inhibitors in KRAS mutant colorectal cancer. Cell
Rep. 7:1940–1955. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maekawa K, Baba T, Otomo S, Morishita S
and Tamura N: Low pre-existing gray matter volume in the medial
temporal lobe and white matter lesions are associated with
postoperative cognitive dysfunction after cardiac surgery. PLoS
One. 9:e873752014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cai Y, Hu H, Liu P, Feng G, Dong W, Yu B,
Zhu Y, Song J and Zhao M: Association between the apolipoprotein E4
and post-operative cognitive dysfunction in elderly patients
undergoing intravenous anesthesia and inhalation anesthesia.
Anesthesiology. 116:84–93. 2012. View Article : Google Scholar
|
|
5
|
Zhang Q, Li SZ, Feng CS, Qu XD, Wang H,
Zhang XN, Liu Y, Wang Y, Wu AS and Yue Y: Serum proteomics of early
post-operative cognitive dysfunction in elderly patients. Chin Med
J (Engl). 125:2455–2461. 2012.
|
|
6
|
Lin K and Abraham KM: Targets of p56(lck)
activity in immature thymoblasts: Stimulation of the Ras/Raf/MAPK
pathway. Int Immunol. 9:291–306. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kleist B, Kempa M, Novy M, Oberkanins C,
Xu L, Li G, Loland C and Poetsch M: Comparison of neuroendocrine
differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in
primary and metastatic colorectal cancer. Int J Clin Exp Pathol.
7:5927–5939. 2014.PubMed/NCBI
|
|
8
|
Sinha R, Larkin J, Gore M and Fearfield L:
Cutaneous toxicities associated with vemurafenib therapy in 107
patients with BRAF V600E mutation-positive metastatic melanoma,
including recognition and management of rare presentations. Br J
Dermatol. 173:1024–1031. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Okamoto K, Okamoto I, Hatashita E, Kuwata
K, Yamaguchi H, Kita A, Yamanaka K, Ono M and Nakagawa K:
Overcoming erlotinib resistance in EGFR mutation-positive non-small
cell lung cancer cells by targeting survivin. Mol Cancer Ther.
11:204–213. 2012. View Article : Google Scholar
|
|
10
|
Cercek A, Shia J, Gollub M, Chou JF,
Capanu M, Raasch P, Reidy-Lagunes D, Proia DA, Vakiani E, Solit DB,
et al: Ganetespib, a novel Hsp90 inhibitor in patients with KRAS
mutated and wild type, refractory metastatic colorectal cancer.
Clin Colorectal Cancer. 13:207–212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Giannoni E, Fiaschi T, Ramponi G and
Chiarugi P: Redox regulation of anoikis resistance of metastatic
prostate cancer cells: Key role for Src and EGFR-mediated
pro-survival signals. Oncogene. 28:2074–2086. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Whelan KA, Schwab LP, Karakashev SV,
Franchetti L, Johannes GJ, Seagroves TN and Reginato MJ: The
oncogene HER2/neu (ERBB2) requires the hypoxia-inducible factor
HIF-1 for mammary tumor growth and anoikis resistance. J Biol Chem.
288:15865–15877. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oh HY, Lee EJ, Yoon S, Chung BH, Cho KS
and Hong SJ: Cholesterol level of lipid raft microdomains regulates
apoptotic cell death in prostate cancer cells through EGFR-mediated
Akt and ERK signal transduction. Prostate. 67:1061–1069. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Roomi MW, Kalinovsky T, Rath M and
Niedzwiecki A: In vitro modulation of MMP-2 and MMP-9 in pediatric
human sarcoma cell lines by cytokines, inducers and inhibitors. Int
J Oncol. 44:27–34. 2014.
|
|
15
|
Lawless N, Vegh P, O'Farrelly C and Lynn
DJ: The role of microRNAs in bovine infection and immunity. Front
Immunol. 5:6112014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cortés-Sempere M and Ibáñez de Cáceres I:
microRNAs as novel epigenetic biomarkers for human cancer. Clin
Transl Oncol. 13:357–362. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rotomskis A, Margevičiūtė R, Germanavičius
A, Kaubrys G, Budrys V and Bagdonas A: Differential diagnosis of
depression and Alzheimer's disease with the Addenbrooke's Cognitive
Examination-Revised (ACE-R). BMC Neurol. 15:572015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yen SS: Proteasome degradation of brain
cytosolic tau in Alzheimer's disease. Int J Clin Exp Pathol.
4:385–402. 2011.PubMed/NCBI
|
|
19
|
Zheng J, Wu C, Xu Z, Xia P, Dong P, Chen B
and Yu F: Hepatic stellate cell is activated by microRNA-181b via
PTEN/Akt pathway. Mol Cell Biochem. 398:1–9. 2015. View Article : Google Scholar
|
|
20
|
Jun Z, Li Z, Fang W, Fengzhen Y, Puyuan W,
Wenwen L, Zhi S and Bondy SC: Melatonin decreases levels of S100β
and NFKB, increases levels of synaptophysin in a rat model of
Alzheimer's disease. Curr Aging Sci. 6:142–149. 2013. View Article : Google Scholar
|
|
21
|
Granic I, Dolga AM, Nijholt IM, van Dijk G
and Eisel UL: Inflammation and NF-kappaB in Alzheimer's disease and
diabetes. J Alzheimers Dis. 16:809–821. 2009.PubMed/NCBI
|
